Reports from Toutiao indicate that a leading Chinese fintech company is in discussions to acquire blockchain technology from the Venom 0 details of the negotiations remain confidential, sources suggest the goal is to integrate Venom’s infrastructure into financial services that support the real economy, from supply chain finance to cross-border 1 talks echo a familiar 2 companies have a track record of moving into blockchain and digital asset sectors through bold acquisitions or strategic pivots, triggering market 3 notable case came from the crypto exchange Huobi, which pursued a strategy of overseas acquisitions starting in 2018, buying licenses and platforms in Japan and Singapore after Beijing tightened domestic 4 strategy enabled Huobi to maintain a global presence despite restrictions at home, though it also underlined how Chinese players often rely on foreign partnerships to keep pace with global 5 employs dynamic sharding to handle high transaction volumes and bottlenecks, a fair-ordering layer to address market manipulation issues, and cross-chain interoperability with Ethereum Virtual Machine (EVM) and Web Assembly (WASM).
However, analysts note that supply chain finance would benefit the most from Venom’s blockchain-based data credit 6 applications are 7 chain finance has long been a bottleneck for small and medium-sized enterprises, where banks hesitate to extend credit due to limited 8 could help build a transparent “data credit” system to reduce that 9 investors, the possible Venom deal raises familiar 10 it mirror Huobi’s experience, where overseas acquisitions became the foundation for long-term strategy despite regulatory headwinds? The negotiations are expected to extend into late 2025 or early 11 of the outcome, the story reflects a broader structural shift: blockchain is steadily moving into the infrastructure layer of China’s financial 12 image via Shutterstock
Story Tags

Latest news and analysis from Finbold


